Skip to content
StockMarketAgent
Consumer Staples / Packaged FoodsUpdated 2026-05-10 22:07 UTC

RKDA stock hub

Arcadia Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

RKDAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.2M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
RKDA
In the news

Latest news · RKDA

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.3P50 15.2P75 20.1
Trailing P/En/a
P25 12.9P50 17.8P75 28.8
ROE-45.1
P25 -17.2P50 6.8P75 17.2
ROIC-62.4
P25 -6.6P50 6.3P75 13.6
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All RKDA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
203
Groups with data
11
Currency
USD
Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001469443
Company name
Arcadia Biosciences, Inc.
Country
United States
Country code
US
Cusip
039014204
Employees
8
Employees Change
-1%
Employees Change Percent
-11.11
Enterprise value
$-2.4M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Packaged Foods
IPO Date
2015-05-15
Isin
US0390143032
Last refreshed
2026-05-10
Market cap
$2.2M
Market cap category
Nano-Cap
Price
$1.07
Price currency
USD
Rev Per Employee
607,250x
Sector
Consumer Staples
Sic
1311
Symbol
RKDA
Website
https://arcadiabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-106.28%
FCF yield
-215.32%
P/B ratio
0.35x
P/S ratio
0.45x
PS Forward
0.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-108.07%
EBITDA Margin
-107.41%
Gross margin
36.04%
Gross Profit
$1.8M
Gross Profit Growth
-19.79%
Gross Profit Growth Q
-63.77%
Gross Profit Growth3 Y
-4.4%
Net Income
$-2.3M
Net Income Growth Quarters
2%
Net Income Growth Years
3%
Pretax Margin
-47.98%
Profit Margin
-48.15%
Profit Per Employee
$-292,375
ROA
-32.71
Roa5y
-24.3
ROCE
-117
ROE
-45.14
Roe5y
-38.22
ROIC
-62.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-51.35%
Cagr1y
-75.14%
Cagr3y
-44.67%
Cagr5y
-59.97%
EPS Growth Quarters
2
EPS Growth Years
4
Revenue Growth
-3.71x
Revenue Growth Q
-25.91x
Revenue Growth Years
0x
Revenue Growth3 Y
-0.94x
Revenue Growth5 Y
-9.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
$0.48
Assets
$6.5M
Cash
$4.6M
Current Assets
$6.4M
Current Liabilities
$2.1M
Equity
$4.1M
Liabilities
$2.4M
Long Term Assets
$190,000
Long Term Liabilities
$347,000
Net Cash
$4.6M
Net Cash By Market Cap
$207
Net Cash Growth
11.65%
Net Debt Equity
$-1.1
Tangible Book Value
$4.1M
Tangible Book Value Per Share
$2.99
WACC
7.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.09
Inventory Turnover
2.94
Net Working Capital
$-266,000
Quick ratio
2.42
Working Capital
$4.3M
Working Capital Turnover
$0.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-0.35%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

41
MetricValue
10Y total return
-99.93%
1Y total return
-75.12%
200-day SMA
2.88
3Y total return
-83.07%
50-day SMA
1.46
50-day SMA vs 200-day SMA
50under200
5Y total return
-98.97%
All Time High
7,040
All Time High Change
-99.98%
All Time High Date
2015-06-12
All Time Low
0.89
All Time Low Change
20.22%
All Time Low Date
2026-04-17
ATR
0.11
Beta
0.52
Beta1y
0.94
Beta2y
1.81
Ch YTD
-45.96
High
1.15
High52
6.71
High52 Date
2025-10-08
High52ch
-84.05%
Low
1.07
Low52
0.89
Low52 Date
2026-04-17
Low52ch
20.23%
Ma50ch
-26.66%
Premarket Change Percent
-4.55
Premarket Price
$1.05
Premarket Volume
520
Price vs 200-day SMA
-62.82%
RSI
35.09
RSI Monthly
33.15
RSI Weekly
29.38
Sharpe ratio
-1.03x
Sortino ratio
-1.53
Total Return
-0.35%
Tr YTD
-45.96
Tr1m
-18.32%
Tr1w
-4.46%
Tr3m
-40.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Earnings EPS Estimate
$-0.8
Earnings Revenue Estimate
1,600,000x
Earnings Revenue Estimate Growth
33.33x
Operating Income
$-5.3M
Operating margin
-108.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
2,045,669%
Float Percent
99.45%
Shares Insiders
0.55%
Shares Institutions
1.9%
Shares Out
2,056,884
Shares Qo Q
0%
Shares Yo Y
0.35%
Short Float
0.08%
Short Ratio
0.07
Short Shares
0.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-5M
Average Volume
31,596.25x
Bv Per Share
3.02
Ch10y
-99.93
Ch1m
-18.32
Ch1w
-4.46
Ch1y
-75.12
Ch3m
-40.56
Ch3y
-83.07
Ch5y
-98.97
Ch6m
-71
Change
-2.73%
Change From Open
-5.31
Close
1.1
Days Gap
2.73
Depreciation Amortization
32,000
Dollar Volume
27,239
Earnings Date
2026-05-22
Earnings Time
bmo
EBIT
$-5.3M
EBITDA
$-5.2M
EPS
$-1.71
F Score
1
FCF
$-4.7M
FCF EV Yield
200.62x
FCF Per Share
$-2.3
Financing CF
6,000
Fiscal Year End
December
Founded
2,002
Income Tax
$8,000
Investing CF
750,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-26
Last Report Date
2025-12-31
Last Split Date
2023-03-01
Last Split Type
Reverse
Last10k Filing Date
2026-03-26
Ma150
2.54
Ma150ch
-57.86%
Ma20
1.15
Ma20ch
-7.2%
Net CF
-3,983,000
Next Earnings Date
2026-05-22
Open
1.13
Optionable
No
Position In Range
0
Post Close
1.07
Postmarket Change Percent
-1.87
Postmarket Price
$1.05
Ppne
8,000
Pre Close
1.1
Price Date
2026-05-08
Ptbv Ratio
0.54
Relative Volume
0.81x
Revenue
4,858,000x
SBC By Revenue
4.82x
Share Based Comp
234,000
Tax By Revenue
0.16x
Tr6m
-71%
Us State
Texas
Volume
25,457
Z Score
-59.89
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does RKDA pay a dividend?

Capital-return profile for this ticker.

Performance

RKDA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-75.1%
S&P 500 1Y: n/a
3Y total return
-83.1%
S&P 500 3Y: n/a
5Y total return
-99.0%
S&P 500 5Y: n/a
10Y total return
-99.9%
S&P 500 10Y: n/a
Ownership

Who owns RKDA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.9%
Float: +99.5% of shares outstanding
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+0.1%
0.1 days to cover
Y/Y dilution
+0.3%
Negative means the company is buying back shares.
Technical

RKDA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
35.1
Neutral momentum band
Price vs 200-day MA
-62.8%
50/200-day relationship not available
Beta (5Y)
0.52
Less volatile than the market
Sharpe ratio
-1.03
Risk-adjusted return — higher is better; >1.0 is solid.
Peers

RKDA vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

TickerNameMarket capP/EP/SROIC5Y rev CAGR1Y total returnRating
COSTCostco Wholesale Corporation447.6B52.5x1.6x37.8%+9.9%+0.7%ขาย
KOThe Coca-Cola Company337.4B24.7x6.8x19.6%+8.1%+11.5%ซื้อมาก
MDLZMondelez International Inc.79B30.4x2.0x6.3%+7.7%-5.3%ซื้อ
Questions

About RKDA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RKDA stock rating?

Arcadia Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RKDA analysis?

The full report lives at /stocks/RKDA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RKDA?

The latest report frames RKDA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RKDA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.